Finance

Lists
W5L:FRA
Chosa Oncology AB
€0.043
-0.46%
(-0.00020) 1D
Sep 3, 8:03:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for W5L...
Open
€0.04
High
€0.04
Low
€0.04
Volume
0.00
52-wk high
€0.15
52-wk low
€0.04
No. of employees
2
Open
€0.04
High
€0.04
Low
€0.04
Volume
0.00
52-wk high
€0.15
52-wk low
€0.04
No. of employees
2
About Chosa Oncology AB
CEO-
Employees2
Founded2007
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-3.93M
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.48M
4.07M
1.96M
2.84M
Operating expense
2.49M
794.00K
1.96M
2.84M
Total operating expenses
2.49M
794.00K
1.96M
2.84M
Operating income
-2.49M
-4.72M
-1.96M
-2.84M
Other non operating income
-52.00K
-8.75K
-2.00K
1.00K
EBT including unusual items
-2.54M
-4.92M
-1.87M
-2.63M
EBT excluding unusual items
-2.54M
-4.92M
-1.87M
-2.63M
Income tax expense
-
-1.01M
-
-
Effective tax rate
-
20.60%
-
-
Other operating expenses
5.00K
-3.93M
-2.00K
1.00K
Net income
-2.54M
-3.91M
-1.87M
-2.63M
Net profit margin
-
99.41%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
310.20K
95.00K
248.00K
Interest expense
-
-116.05K
-2.00K
-43.00K
Net interest expenses
-
194.16K
93.00K
205.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.46M
-4.08M
-1.78M
-2.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps